Trimetazidine

Prevention of angina following PCI with trimetazidine MR 35 mg in patients with coronary artery disease

Stage
klaar
Medicine
trimetazidine MR Vastarel
Population
ASCVD
Phase
III
First Patient In
1 January 2014
Last Patient In
-
Last Patient Last Visit
-

Study Director

drs. C. van der Zwaan

Cardioloog

The page has expired.